Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tovorafenib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4DAY ONE BIOPHARMS

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    DAY ONE BIOPHARMS

    TOVORAFENIB

    arrow
    Antibody Engineering
    Not Confirmed

    DAY ONE BIOPHARMS

    Country
    arrow
    Antibody Engineering
    Not Confirmed

    Patent Expiration Date : 2035-06-23

    TOVORAFENIB

    US Patent Number : 10426782

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 217700

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2035-06-23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    DAY ONE BIOPHARMS

    TOVORAFENIB

    arrow
    Antibody Engineering
    Not Confirmed

    DAY ONE BIOPHARMS

    Country
    arrow
    Antibody Engineering
    Not Confirmed

    Patent Expiration Date : 2031-08-04

    TOVORAFENIB

    US Patent Number : 8293752

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 218033

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2031-08-04

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    DAY ONE BIOPHARMS

    TOVORAFENIB

    arrow
    Antibody Engineering
    Not Confirmed

    DAY ONE BIOPHARMS

    Country
    arrow
    Antibody Engineering
    Not Confirmed

    Patent Expiration Date : 2031-08-04

    TOVORAFENIB

    US Patent Number : 8293752

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 217700

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2031-08-04

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    DAY ONE BIOPHARMS

    TOVORAFENIB

    arrow
    Antibody Engineering
    Not Confirmed

    DAY ONE BIOPHARMS

    Country
    arrow
    Antibody Engineering
    Not Confirmed

    Patent Expiration Date : 2035-06-23

    TOVORAFENIB

    US Patent Number : 10426782

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 218033

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2035-06-23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF